Voriconazole
26 Inquiries
137234-62-9
95%
2026-07-24
Coenzymes,Inhibito,Enzymes,Zymogens,Substrates,Native Microorganism Creatine Amidinohydrolase
-
Product Description
-
Seller Information
-
Inquiry History
-
Description
ProductName Voriconazole Cat No CEI-1164 Description Voriconazole (VFEND) is a triazole antifungal medication that is generally used to treat serious, invasive fungal infections. Abbr Voriconazole(Anti Fungal) CAS No 137234-62-9 Molecular Weight 349.31 Purity > 95% Storage 4 centigrade Targets Anti Fungal Molecular Formula C16H14F3N5O Chemical Name (2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol category Synthetic Anti-infective Drugs(c1421) cas_num 137234-62-9 Basic Info-
Product Name:
Voriconazole
Other Name:4-Pyrimidineethanol,α-(2,4-difluorophenyl)-5-fluoro-β-methyl-α-(1H-1,2,4-triazol-1-ylmethyl)-,(αR,βS)-;4-Pyrimidineethanol,α-(2,4-difluorophenyl)-5-fluoro-β-methyl-α-(1H-1,2,4-triazol-1-ylmethyl)-,[R-(R*,S*)]-;(αR,βS)-α-(2,4-Difluorophenyl)-5-fluoro-β-methyl-α-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol;Voriconazole;UK 109496;Vfend;DRG 0301;VRC;Voriconazol;G-573;173967-54-9
CAS No.:137234-62-9
Molecular Formula:C16H14F3N5O
InChIKeys:InChIKey=BCEHBSKCWLPMDN-MGPLVRAMSA-N
Molecular Weight:349.31
Exact Mass:349.31
EC Number:200-261-5
HScode:29335990
Categories:
Characteristics-
PSA:
76.7
XLogP3:1.5
Appearance:Solid
Density:1.42±0.1 g/cm3(Predicted)
Melting Point:127-130°C
Boiling Point:508.6ºC at 760 mmHg
Flash Point:9℃
Refractive Index:1.617
Water Solubility:DMSO: >20mg/mL
Storage Conditions:Store at +4°C
Vapor Pressure:3.63E-11mmHg at 25°C
Specific rotation:D25 -62° (c = 1 in methanol)
Hazard IdentificationClassification of the substance or mixture
Acute toxicity - Category 3, Oral
Carcinogenicity, Category 2
Reproductive toxicity, Category 2
Specific target organ toxicity â repeated exposure, Category 2
Hazardous to the aquatic environment, short-term (Acute) - Category Acute 1
Hazardous to the aquatic environment, long-term (Chronic) - Category Chronic 3
GHS label elements, including precautionary statements
Pictogram(s) 
Signal word Danger
Hazard statement(s) H301 Toxic if swallowed
H351 Suspected of causing cancer
H361 Suspected of damaging fertility or the unborn child
H373 May cause damage to organs through prolonged or repeated exposure
H400 Very toxic to aquatic life
H412 Harmful to aquatic life with long lasting effects
Precautionary statement(s) Prevention P264 Wash ... thoroughly after handling.
P270 Do not eat, drink or smoke when using this product.
P203 Obtain, read and follow all safety instructions before use.
P280 Wear protective gloves/protective clothing/eye protection/face protection/hearing protection/...
P260 Do not breathe dust/fume/gas/mist/vapours/spray.
P273 Avoid release to the environment.
Response P301+P316 IF SWALLOWED: Get emergency medical help immediately.
P321 Specific treatment (see ... on this label).
P330 Rinse mouth.
P318 IF exposed or concerned, get medical advice.
P319 Get medical help if you feel unwell.
P391 Collect spillage.
Storage P405 Store locked up.
Disposal P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Manufactory
-
Main Products:
Coenzymes,Inhibito,Enzymes,Zymogens,Substrates,Native Microorganism Creatine Amidinohydrolase
-
Location:
Shirley, New York 11967, USA
-
Payment Terms:
TT against copy of documents,D/P
-
Average lead Time:
15
-
Total Annual Revenue:
$1 million-$2.5 million
-
Year of Establishment:
2004
-
-
Inquiry History26 Inquiries
Country Product Purchase Quantity Date Posted 
Pakistan
VORICONAZOLE
50 KG Dec 8, 2025 
United States
Voriconazole
1 KG Dec 1, 2025
Pakistan
VORICONAZOLE
25 KG Jun 20, 2025
Pakistan
VORICONAZOLE
15 KG Mar 17, 2025
Pakistan
VORICONAZOLE
30 KG Oct 17, 2024
Pakistan
Voriconazole
25.00 KG May 6, 2024
Pakistan
Voriconazole USP
5 KG Sep 21, 2023
United States
voriconazole
10 MG May 26, 2026
Pakistan
Voriconazole
1 KG Apr 17, 2026
Pakistan
VORICONAZOLE
50 KG Dec 9, 2025
Pakistan
Voriconazole
30 KG Aug 12, 2025
Pakistan
Voriconazole
10 KG Jun 5, 2025
Pakistan
Voriconazole
10 KG Sep 3, 2024
Pakistan
Voriconazole
4.2 KG Apr 25, 2024
Pakistan
Voriconazole
5 KG Oct 11, 2023
Pakistan
Voriconazole
20 KG May 21, 2026
Pakistan
VORICONAZOLE
1 KG Apr 21, 2026 
Bangladesh
Voriconazole
300 KG Feb 25, 2026
Pakistan
VORICONAZOLE
50 KG Feb 25, 2026
Pakistan
Voriconazole
10 KG Oct 17, 2025 Post an enquiry for this product